Mercado global de vacinas contra a febre efémera bovina – Tendências do setor e previsão para 2030

Análise e dimensão do mercado de vacinas contra a febre efémera bovina

A febre efémera bovina é um tipo de doença do gado e dos búfalos que é causada por um rabdovírus e é transmitida por insetos que picam e voam. Devido à natureza inflamatória da doença, os AINE são muito eficientes no alívio dos sinais clínicos e da dor. A crescente procura por parte das empresas farmacêuticas está entre os fatores importantes que intensificam o crescimento e a procura do mercado global de vacinas contra a febre efémera bovina. Além disso, o crescente habitante geriátrico em todo o mundo está também a contribuir para o crescimento do mercado global durante o período previsto de 2023 a 20230.

A Data Bridge Market Research analisa que o mercado global de vacinas contra a febre efémera bovina foi avaliado em 70,34 milhões de dólares em 2022 e estima-se ainda que atinja os 90,49 milhões de dólares até 2030, devendo crescer a um CAGR de 3,2% durante o período de previsão de 2023 até 2030. O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito e segmentação do mercado de vacinas contra a febre efémera bovina

Market Definition

The global bovine ephemeral fever vaccine market refers to the market for vaccines specifically designed for the prevention and control of global bovine ephemeral fever worldwide. Bovine ephemeral fever, also known as three-day disease, is a viral disease that mainly affects cattle and sometimes water buffalo. It is caused by the bovine ephemeral fever virus, which is spread by insect vectors, especially mosquitoes.

Global bovine ephemeral fever vaccine market includes the production, distribution and sale of vaccines immunizing.  These vaccines are developed using various techniques, including inactivated vaccines, live attenuated vaccines and combination vaccines. They are designed to stimulate the immune response of cattle, develop immunity against global bovine ephemeral fever and reduce the severity and duration of the disease.

Bovine Ephemeral Fever Vaccines Market Dynamics

Drivers

• Increasing Prevalence of Bovine Ephemeral Fever

Rising incidence of short-lived bovine fever, a viral disease of cattle, is a major driving factor for the global short-lived bovine fever vaccine market. As the disease can cause huge economic losses to the livestock industry, there is a growing demand for effective vaccines to prevent its spread. This impetus is expected to boost the market growth of short-lived bovine fever vaccine.

• Growing Awareness and Government Initiatives

Growing awareness among ranchers and governments about the importance of vaccination to combat short-lived bovine fever has increased the demand for vaccines. Governments around the world have implemented vaccination programs and efforts to limit the impact of the disease on cattle populations. It is hoped that these efforts will facilitate the introduction of a short-lived bovine fever vaccine.

• Advancements in Vaccine Technology

Technological advances in vaccine development have produced more efficient and safer short-lived bovine fever vaccines. New vaccine formulations, improved delivery methods, and enhanced immune responses are having a positive impact on the market. The availability of advanced vaccines has facilitated the introduction and use of short-acting bovine fever vaccines.

Opportunities

• Untapped Regional Markets

There are some untapped regional markets with large cattle populations that have not yet introduced a short-lived bovine fever vaccine on a large scale. Expanding market reach into these regions represents significant growth opportunities for vaccine makers, and targeting these untapped markets could lead to increased sales and market expansion.

• Upsurge in R and D for New Vaccine Candidates

Research and development (R and D) efforts focused on developing new, more effective, short-lived bovine fever vaccines could create lucrative opportunities in the market. Investing in research and development of new vaccine candidates with improved efficacy, safety, and long-term persistence from disease can attract significant attention and market share.

Restraints/ Challenges

• Lack of Awareness and Infrastructure in Developing Regions

A major barrier to the global short-lived bovine fever vaccine market is lack of awareness and infrastructure in some developing regions. In these areas, farmers may not have access to good information about diseases and vaccine availability. Moreover, lack of cold chain facilities for storage and distribution of vaccines poses a challenge to the market growth in these regions.

• Limited Research Data and Knowledge

A challenge for the global short-lived global bovine fever vaccine market is the limited availability of comprehensive research data and knowledge on this disease. Further research and data collection on epidemiology, vaccine efficacy and long-term immunity are needed to better understand and improve vaccine development. Lack of solid data may hinder the potential growth of the market and limit the progress of the short-lived bovine fever vaccine.

This global bovine ephemeral fever vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bovine ephemeral fever vaccines market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2019, Zoetis launched "Bovilis Bovine Ephemeral Fever," a live attenuated vaccine for the prevention of bovine ephemeral fever in cattle
• In November 2018, Zoetis acquired Abaxis, a leading global provider of veterinary diagnostic instruments, to strengthen its presence in the animal health diagnostics market

Global Bovine Ephemeral Fever Vaccines Market Scope

The bovine ephemeral fever vaccines market is segmented on the basis of vaccine type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Vaccine Type

• Live Vaccine
• Killed Vaccine
• Others

Application

• Cattle
• Water Buffaloes

End Users

• Medical Device Companies
• Pharmaceutical Industries
• Animal Hospitals
• Other End Users

Global Bovine Ephemeral Fever Vaccines Market Regional Analysis/Insights

The global bovine ephemeral fever vaccines market is analyzed and market size insights and trends are provided by country, vaccine type, application and end users as referenced above.     

The countries covered in the Global Bovine Ephemeral Fever Vaccines Market report are the U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America dominates the global bovine ephemeral fever vaccines market due to the new product launches and early treatment adoption within the region.

 Asia-Pacific is expected to witness the fastest growth during the forecast period 2023-2030 because of the rise in the healthcare expenditure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global bovine ephemeral fever vaccines market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global bovine ephemeral fever vaccines market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global bovine ephemeral fever vaccines market. The data is available for historic period 2015-2020.

Competitive Landscape and Bovine Ephemeral Fever Vaccines Market Share Analysis

O panorama competitivo do mercado de vacinas contra a febre efémera bovina fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado global de vacinas contra a febre efémera bovina.

Alguns dos principais players que trabalham no mercado das vacinas contra a febre efémera bovina são:

• Zoetis Services LLC (EUA)
• Nutri Pharmax Sdn Bhd (Malásia)
• Octavoscene (Pty) Ltd (África do Sul)
• Kyoto Biken Laboratories, Inc.
• Indian Immunologicals Ltd. (Índia)
• Rede CAVAC (França)

SKU-60033